Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Pharma Industry News GSK reveals significant Shingrix vaccine efficacy in ZOSTER-049 trial GSK plc announced the results of the ZOSTER-049 phase III long-term follow-up trial, showcasing that the Shingrix (Recombinant… byPallavi MadhirajuApril 18, 2024